SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 12.42.
| Share Price | ₹588.7 | Nov 21,2025 |
| Market Cap | ₹22,521.7 Cr | |
| Sales-TTM | ₹1,814.1 Cr | TTM-Consolidated Results |
| Price/Sales | 12.42x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹22,521.7 Cr] as on Nov 21,2025
(/) Sales [ ₹1,814.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 12.42x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '12.42 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 14.89x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 12.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 24.66x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 8.98x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUVEN PHARMACEUTICALS | 1,814.1 | 12.42 | 22,521.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.77 | 427,034.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.87 | 169,211.0 |
| CIPLA LTD | 28,349.6 | 4.31 | 122,082.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.20 | 124,875.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.03 | 103,873.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.82 | 92,581.7 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.80 | 93,026.3 |
| LUPIN LTD | 24,750.7 | 3.74 | 92,663.3 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.15 | 70,004.0 |
| ABBOTT INDIA LTD | 6,714.4 | 9.35 | 62,806.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.15x |
| Max industry PS | 16.87x |
| Median industry PS | 6.82x |
| Average industry PS | 7.31x |
You may also like the below Video Courses